Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Chest|April 28, 2023
Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort StudyLisa M Hessels, Esther Speksnijder, Nienke Paternotte, et al.The Netherlands Journal of Medicine|March 16, 2012
SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adultsW J Wiersinga, M J Bonten, W G Boersma, et al.Chemical Research in Toxicology|September 21, 2004
Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafroleSuzanne M F Jeurissen, Jan J P Bogaards, Hanem M Awad, et al.The Netherlands Journal of Medicine|January 31, 2018
Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)W J Wiersinga, M J Bonten, W G Boersma, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2026
Impact of low-dose chest CT and multiplex PCR on antibiotic usage for community-acquired pneumonia: multicentre prospective controlled before-after study with cluster randomisation (CAP-NEXT study)L Zhang, R M Aleva, H S M Ammerlaan, et al.Chemical Research in Toxicology|January 18, 2006
Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenolSuzanne M F Jeurissen, Jan J P Bogaards, Marelle G Boersma, et al.The European Respiratory Journal|February 12, 2013
Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumoniaSusanne M Huijts, Michael W Pride, Josephine M I Vos, et al.The New England Journal of Medicine|April 2, 2015
Antibiotic treatment strategies for community-acquired pneumonia in adultsDouwe F Postma, Cornelis H van Werkhoven, Leontine J R van Elden, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2020
Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guidelineElske Sieswerda, Mark G J de Boer, Marc M J Bonten, et al.The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.Pageof 17